查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1926772

按活性成分、配方、价格范围、应用和通路的药用漱口水市场—2026-2032年全球预测

Pharmaceutical Mouthwash Market by Active Ingredient, Formulation, Price Tier, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，药用漱口水市场价值将达到 30.5 亿美元，到 2026 年将成长至 31.9 亿美元，到 2032 年将达到 41.7 亿美元，年复合成长率为 4.53%。

关键市场统计数据
基准年 2025 30.5亿美元
预计年份：2026年 31.9亿美元
预测年份 2032 41.7亿美元
复合年增长率 (%) 4.53%

受临床需求、消费者偏好和分销管道创新等因素的驱动，漱口水市场正迅速发展。配方科学、牙科实践和零售分销等各方相关人员正在重新定义产品价值提案，以平衡抗菌功效、患者耐受性和天然性认知。同时，监管机构日益关註消毒剂安全性和抗生素合理使用，迫使生产商重新评估其活性成分策略和标籤标註方式。

具体而言，研发团队必须在应对日益复杂的供应链的同时，将临床终点与消费者利益结合。製造商正积极优化防腐体系和风味配方，以提高依从性，尤其是在牙科手术后患者和牙周病患者等弱势群体中。同时，临床医生和牙科网路正在采用实证通讯协定来影响采购政策和产品推荐，从而加强临床疗效与商业性应用之间的关联。因此，能够同时展现临床严谨性和消费者吸引力的公司，更有可能与专业合作伙伴和零售合作伙伴建立更牢固、更长期的合作关係。

抗菌药物管理、消费者期望、数位商务、日益严格的监管以及供应链韧性正在重新定义该行业的竞争优势。

漱口水产业正在加速经历多项变革。首先，抗菌药物管理与疗效需求之间的平衡，促使人们对传统活性成分（如氯化十六烷基吡啶和氯己定）进行更严格的审查，同时也推动了人们对替代疗法（包括精油和草药萃取物）的兴趣。其次，主导兼具临床疗效和感官体验的产品的需求日益增长，正在重塑蓝图，除了传统的液体漱口水外，调味凝胶和特製凝胶产品也成为研发重点。

评估近期关税调整对整个产业的采购决策、製造地和通路定价策略的影响

2025年实施的关税调整带来的累积影响，正促使整个漱口水产业在采购、配方经济性和定价策略方面面临新的挑战。进口成本压力迫使多家製造商重新审视其原料采购策略，转向关键活性成分和辅料的区域供应商，以减轻关税波动的影响。因此，采购团队正在进行更细緻的成本效益分析和情境规划，以在确保产品效能的同时，维持利润率。

深度細項分析揭示了成分、应用、配方、通路和价格点如何驱动不同的开发和商业化路径。

基于细分市场的洞察揭示了活性成分、应用、配方、分销管道和价格点等方面的细微机会和独特的营运需求。诸如氯化十六烷基吡啶、氯己定、精油、氟化物和草药萃取物等活性成分具有不同的特性，因此需要根据临床结果客製化活性成分策略。每种成分的特性都有不同的证据要求和耐受性考量，这会影响标籤和专家建议。特定应用途径，例如一般口腔卫生、牙周护理、术后护理和美白，都受到不同的监管要求和临床证据阈值。这意味着产品开发时间表和研究设计必须根据预期用途进行调整。

区域策略差异和业务重点影响全球主要地区的产品开发、监管规划和分销管道投资

区域趋势正在以不同的方式影响美洲、欧洲、中东和非洲以及亚太地区的产品组合优先事项、监管策略和分销投资。在美洲，完善的临床指南和在牙科专业管道的强大影响力为临床检验配方和高端定位创造了有利环境，而电子商务的渗透则补充了传统的药局和超级市场分销管道，并支持开展有针对性的消费者教育宣传活动。

製造商如何结合临床投资、配方差异化和分销管道合作来提升产品价值并增强其竞争优势

在漱口水领域，製药公司正透过临床证据的累积、精准的产品组合细分以及针对特定管道的市场推广模式，加速实现差异化。主要企业正投资于超越短期疗效的临床项目，涵盖耐受性、微生物群影响和长期安全性等方面，从而为专家支持和高端产品宣称奠定坚实基础。同时，一些公司正利用其配方科学能力，打造差异化的感官体验和缓释机制，以提高产品留存率。

整合临床检验、产品系列清晰度、全通路部署和供应链韧性的可操作策略重点

产业领导者应采取协调一致的策略，整合科学可信度、以消费者为中心的设计、针对特定管道的商业化以及稳健的供应链结构。首先，应优先进行能够同时解决疗效和耐受性终点的临床项目（包括评估微生物组效应和长期安全性的研究），以获得专家支持并为高价定价提供基础。其次，应设计能够清楚匹配活性成分特性和製剂形式与特定用途（例如牙周护理、术后恢復、美白和日常口腔卫生）的产品系列，以减少渠道摩擦，并提高处方医生和消费者的认知度。

为了支持结论，采用了稳健的混合方法研究途径，结合了专家访谈、监管审查、临床证据评估和跨区域营运分析。

本摘要的研究基础是对一手和二手证据进行系统性综合分析，以确保其见解能够反映真实世界的实践和临床趋势。一级资讯来源包括对製剂科学家、牙科专家、临床网路采购人员以及负责零售和电商管道的商业高管的访谈。此外，还查阅了监管指导文件、临床试验註册资料、专利文献和上市公司披露信息，以检验产品声明和研发轨迹。

对策略要务的最终总结强调了整合临床、商业和营运协作以实现永续优势的必要性。

总之，漱口水市场正从以产品为中心的市场模式向以证据主导、通路意识强的生态系统转型，临床可靠性、配方创新和营运弹性决定着竞争优势。那些将严谨的临床检验与以消费者为导向的感官设计相结合，同时投资于全通路能力和供应链韧性的公司，将更有能力满足不断变化的临床医生期望和消费者偏好。监管趋势和贸易环境虽然增加了市场的复杂性，但也为那些能够快速提供品质保证且符合当地需求的产品的公司创造了新的机会。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依活性成分分類的药用漱口水市场

  • 氯化十六烷基吡啶鎓
  • 氯己定
  • 精油
  • 氟化物
  • 草药萃取物
  • 其他的

9. 按配方分類的药用漱口水市场

  • 形式
  • 凝胶
    • 调味凝胶
    • 无香凝胶
  • 漱口水
  • 喷

第十章：以价格范围分類的药用漱口水市场

  • 经济
  • 中檔
  • 优质的

第十一章 依应用分類的药用漱口水市场

  • 一般口腔卫生
  • 牙周病治疗
  • 术后护理
  • 美白

第十二章 按通路分類的药用漱口水市场

  • 便利商店
  • 牙医诊所和医院
  • 线上零售
    • 品牌官方网站
    • 网路药房
    • 市场
  • 药局
    • 连锁药局
    • 独立药房
  • 超级市场/大卖场

13. 按地区分類的药用漱口水市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 依组别分類的药用漱口水市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国药用漱口水市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国药用漱口水市场

第十七章：中国药用漱口水市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Caldwell Consumer Products Corp.
  • Church & Dwight Co., Inc.
  • Colgate-Palmolive Company
  • Haleon plc
  • Johnson & Johnson
  • Kao Corporation
  • LG Household & Health Care Ltd.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group plc
  • Rhydburg Pharmaceuticals Ltd.
  • Sanofi SA
  • Skan INC.
  • The Procter & Gamble Company
Product Code: MRR-4F7A6D4FF2E2

The Pharmaceutical Mouthwash Market was valued at USD 3.05 billion in 2025 and is projected to grow to USD 3.19 billion in 2026, with a CAGR of 4.53%, reaching USD 4.17 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.05 billion
Estimated Year [2026] USD 3.19 billion
Forecast Year [2032] USD 4.17 billion
CAGR (%) 4.53%

The pharmaceutical mouthwash landscape is undergoing rapid evolution driven by clinical priorities, consumer preferences, and channel innovation. Stakeholders across formulation science, dental practice, and retail distribution are redefining product value propositions to balance antimicrobial efficacy, patient tolerability, and perceived naturalness. At the same time, heightened regulatory attention on antiseptic safety and antimicrobial stewardship is prompting manufacturers to reassess active ingredient strategies and labeling claims.

In practice, this means research and development teams must align clinical endpoints with consumer-facing benefits while navigating increasingly complex supply chains. Manufacturers are actively optimizing preservative systems and flavor profiles to improve compliance, particularly among vulnerable patient groups such as postoperative dental patients and those with periodontal disease. Concurrently, clinicians and dental networks are adopting evidence-based protocols that influence procurement preferences and product endorsements, creating a closer link between clinical validation and commercial uptake. As a result, companies that can demonstrate both clinical rigor and consumer appeal are positioned to build stronger, longer-lasting relationships with professional and retail partners.

How antimicrobial stewardship, consumer sensory expectations, digital commerce, regulatory intensity, and supply chain resilience are redefining competitive advantage in the category

Several transformative shifts are accelerating change across the pharmaceutical mouthwash ecosystem. First, the interplay between antimicrobial stewardship and efficacy demands has elevated scrutiny of traditional actives such as cetylpyridinium chloride and chlorhexidine, and has simultaneously fueled interest in alternative modalities, including essential oils and herbal extracts. Second, consumer-driven demand for products that combine clinical benefits with perceptible sensory experience has prioritized flavored and specialty gels alongside conventional liquid rinses, reshaping R&D roadmaps.

In addition, digital commerce and omnichannel distribution are altering purchase behaviors, with online retail platforms enabling targeted education, subscription models, and replenishment programs that increase repeat purchase potential. Regulatory bodies are also intensifying review pathways, requiring more robust safety data for long-term use claims, which is prompting companies to invest in clinical trials and post-market surveillance. Finally, supply chain resilience and raw material traceability are now core corporate priorities, driving nearshoring and supplier diversification initiatives that influence product cost structures and launch timelines. Taken together, these forces are redefining competitive advantage in the category

Assessment of how recent tariff adjustments have reshaped sourcing decisions, manufacturing footprints, and channel pricing strategies across the sector

The cumulative effects of tariff changes implemented in 2025 have introduced new considerations for sourcing, formulation economics, and pricing strategies across the pharmaceutical mouthwash sector. Import cost pressures have prompted several manufacturers to revisit ingredient sourcing decisions, moving toward regional suppliers for critical actives and excipients in order to reduce exposure to tariff volatility. As a result, procurement teams are engaging in more granular cost-to-serve analysis and scenario planning to preserve margin integrity while maintaining product performance specifications.

Moreover, these trade adjustments have influenced channel strategies, with some firms prioritizing domestic manufacturing for products destined for institutional buyers such as dental clinics and hospitals to avoid cross-border cost escalation. At the same time, online retail channels have absorbed a portion of price sensitivity through promotion mechanics and subscription offerings that smooth price perception for end consumers. The broader implication is that organizations with flexible manufacturing footprints and adaptive pricing frameworks are better positioned to absorb tariff-induced disruption while preserving strategic investments in innovation and clinical validation

Deep segmentation insights revealing how ingredients, applications, formulations, channels, and price tiers drive distinct development and commercial pathways

Segmentation-driven insight reveals nuanced opportunities and distinct operational requirements across active ingredient, application, formulation, distribution channel, and price tier axes. Active ingredient strategy must be tailored to the desired clinical outcome, given the varied properties of cetylpyridinium chloride, chlorhexidine, essential oils, fluoride, herbal extracts, and other actives; each profile carries different evidence expectations and tolerance considerations that will affect labeling and professional endorsement. Application-specific pathways, including general oral hygiene, periodontal treatment, postoperative care, and whitening, impose divergent regulatory and clinical evidence thresholds, meaning product development timelines and trial designs must be calibrated to the intended use case.

Formulation choices are similarly consequential: foam, gel, liquid rinse, and spray formats create unique consumer experiences and dispensing needs, and within gel formats the distinction between flavored and non-flavored variants can materially influence acceptance among sensitive patient cohorts. Distribution strategy requires a differentiated approach as well, since convenience stores, dental clinics and hospitals, online retail channels, pharmacies, and supermarkets or hypermarkets each operate under distinct procurement dynamics and merchandising constraints. Online retail further fragments into brand-owned websites, e-pharmacies, and large marketplaces, while pharmacy distribution differentiates between chain and independent operators; each sub-channel demands tailored marketing, pricing, and service models. Finally, price tier positioning across economy, mid-range, and premium segments shapes formulation complexity, packaging sophistication, and promotional tolerance, necessitating clear trade-offs between cost efficiency and perceived clinical or sensory superiority

Regional strategic differences and operational priorities that influence product development, regulatory planning, and channel investments across major global regions

Regional dynamics are shaping portfolio priorities, regulatory strategies, and distribution investments in distinct ways across the Americas, Europe Middle East and Africa, and Asia-Pacific regions. In the Americas, established clinical guidelines and a strong presence of dental professional channels create a favorable environment for clinically validated formulations and premium positioning, while e-commerce penetration complements traditional pharmacy and supermarket distribution, enabling targeted direct-to-consumer educational campaigns.

Across Europe, the Middle East and Africa, regulatory heterogeneity requires more complex market entry planning, with compliance and clinical evidence needs varying markedly between jurisdictions; this drives a focus on harmonized labeling strategies and adaptive regulatory affairs resourcing. In contrast, the Asia-Pacific region is characterized by rapid retail modernization and strong demand for herbal and natural ingredient platforms, which encourages innovation in herbal extracts and essential oil-based formulations. Additionally, manufacturing capacity in Asia-Pacific plays a central role in global supply chains, prompting companies to balance local demand fulfillment with export considerations and to prioritize quality assurance and supplier verification processes to meet international standards

How manufacturers are combining clinical investment, formulation differentiation, and channel partnerships to elevate product value and strengthen competitive moats

Companies operating in the pharmaceutical mouthwash category are increasingly differentiating through a combination of clinical evidence generation, targeted portfolio segmentation, and channel-specific go-to-market models. Leading manufacturers are investing in clinical programs that extend beyond acute efficacy to include tolerability, microbiome impact, and long-term safety, thereby creating stronger bases for professional endorsement and premium claims. Simultaneously, some organizations are leveraging technological capabilities in formulation science to deliver differentiated sensory profiles and sustained-release mechanisms that enhance adherence.

On the commercial front, strategic partnerships with dental networks and hospital procurement organizations are becoming more prevalent, enabling co-developed clinical pathways and preferred supplier relationships. At the same time, companies are experimenting with direct-to-consumer education strategies through online channels to build brand trust and drive repeat behavior. Operationally, investment in flexible manufacturing platforms, enhanced quality controls, and supplier traceability is becoming a competitive necessity, particularly where regulatory complexity and tariff exposure require rapid response to sourcing constraints. Together, these company-level moves signal a maturation of the category from commodity transactions toward evidence-backed, multi-channel commercial models

Actionable strategic priorities for companies to synchronize clinical validation, portfolio clarity, omnichannel execution, and supply chain resilience

Industry leaders should pursue a coordinated strategy that aligns scientific credibility with consumer-centric design, channel-specific commercialization, and resilient supply chain architecture. First, prioritize clinical programs that address both efficacy and tolerability endpoints, including studies that evaluate microbiome effects and long-term safety, in order to secure professional endorsements and justify premium positioning. Second, design product portfolios that clearly map active ingredient profiles and formulation formats to specific applications such as periodontal care, postoperative recovery, whitening, and everyday hygiene, thereby reducing channel friction and improving clarity for prescribers and consumers.

Third, accelerate digital and omnichannel capabilities by investing in educational content, subscription fulfillment, and targeted promotional mechanics that increase lifetime customer value. Fourth, enhance supply chain resilience by diversifying suppliers, qualifying regional manufacturing partners, and building ingredient traceability into procurement contracts to mitigate tariff and geopolitical risk. Fifth, tailor go-to-market approaches for each distribution channel segment, recognizing the differing requirements of dental clinics, pharmacies, supermarkets, convenience stores, and online sub-channels. Finally, incorporate adaptive pricing strategies across economy, mid-range, and premium tiers to preserve access while protecting margins for innovation-driven products

Robust mixed-methods research approach blending expert interviews, regulatory reviews, clinical evidence assessment, and cross-regional operational analysis to underpin conclusions

The research underpinning this summary combined a structured synthesis of primary and secondary evidence to ensure findings reflect operational realities and clinical trends. Primary inputs included interviews with formulation scientists, dental professionals, procurement leads within clinical networks, and commercial executives responsible for retail and e-commerce channels. These conversations were complemented by a review of regulatory guidance documents, clinical study registries, patent literature, and publicly available company disclosures to validate product claims and development trajectories.

Secondary analysis incorporated cross-regional comparisons of regulatory approaches and distribution models, and operational assessment of manufacturing footprints and supplier relationships. Data triangulation was applied to reconcile differing viewpoints, with emphasis placed on clinical endpoints, adoption dynamics within professional channels, and observable changes in distribution behavior. Quality controls included source verification, consistency checks across independent expert interviews, and a rigorous audit trail documenting the provenance of strategic assertions to support actionable recommendations

Final synthesis of strategic imperatives highlighting the necessity of integrated clinical, commercial, and operational alignment to capture durable advantage

In conclusion, the pharmaceutical mouthwash category is transitioning from a product-centered marketplace to an evidence-driven, channel-aware ecosystem where clinical credibility, formulation innovation, and operational agility determine competitive standing. Companies that integrate rigorous clinical validation with consumer-oriented sensory design, while simultaneously investing in omnichannel capabilities and supply chain resilience, will be best positioned to meet evolving clinician expectations and consumer preferences. Regulatory developments and trade dynamics add layers of complexity, but they also create opportunities for firms that can respond quickly with quality-assured, locally relevant offerings.

Looking forward, success will favor organizations that adopt a systems-level perspective-aligning R&D, regulatory, manufacturing, and commercial teams around clear segmentation strategies and measurable adoption metrics. By doing so, firms can convert insight into durable advantages across professional and consumer channels

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Mouthwash Market, by Active Ingredient

  • 8.1. Cetylpyridinium Chloride
  • 8.2. Chlorhexidine
  • 8.3. Essential Oils
  • 8.4. Fluoride
  • 8.5. Herbal Extracts
  • 8.6. Miscellaneous

9. Pharmaceutical Mouthwash Market, by Formulation

  • 9.1. Foam
  • 9.2. Gel
    • 9.2.1. Flavored Gel
    • 9.2.2. Non Flavored Gel
  • 9.3. Liquid Rinse
  • 9.4. Spray

10. Pharmaceutical Mouthwash Market, by Price Tier

  • 10.1. Economy
  • 10.2. Mid Range
  • 10.3. Premium

11. Pharmaceutical Mouthwash Market, by Application

  • 11.1. General Oral Hygiene
  • 11.2. Periodontal Treatment
  • 11.3. Postoperative Care
  • 11.4. Whitening

12. Pharmaceutical Mouthwash Market, by Distribution Channel

  • 12.1. Convenience Stores
  • 12.2. Dental Clinics & Hospitals
  • 12.3. Online Retail
    • 12.3.1. Brand Websites
    • 12.3.2. E Pharmacies
    • 12.3.3. Marketplace
  • 12.4. Pharmacy
    • 12.4.1. Chain Pharmacies
    • 12.4.2. Independent Pharmacies
  • 12.5. Supermarket/Hypermarket

13. Pharmaceutical Mouthwash Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceutical Mouthwash Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceutical Mouthwash Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pharmaceutical Mouthwash Market

17. China Pharmaceutical Mouthwash Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Caldwell Consumer Products Corp.
  • 18.6. Church & Dwight Co., Inc.
  • 18.7. Colgate-Palmolive Company
  • 18.8. Haleon plc
  • 18.9. Johnson & Johnson
  • 18.10. Kao Corporation
  • 18.11. LG Household & Health Care Ltd.
  • 18.12. Prestige Consumer Healthcare Inc.
  • 18.13. Reckitt Benckiser Group plc
  • 18.14. Rhydburg Pharmaceuticals Ltd.
  • 18.15. Sanofi S.A.
  • 18.16. Skan INC.
  • 18.17. The Procter & Gamble Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CETYLPYRIDINIUM CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CETYLPYRIDINIUM CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CETYLPYRIDINIUM CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHLORHEXIDINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHLORHEXIDINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHLORHEXIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLUORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLUORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLUORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MISCELLANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MISCELLANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MISCELLANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FOAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FOAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FOAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLAVORED GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLAVORED GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FLAVORED GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY NON FLAVORED GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY NON FLAVORED GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY NON FLAVORED GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY LIQUID RINSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY LIQUID RINSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY LIQUID RINSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ECONOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ECONOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ECONOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MID RANGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MID RANGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MID RANGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PREMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PREMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PREMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GENERAL ORAL HYGIENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GENERAL ORAL HYGIENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GENERAL ORAL HYGIENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PERIODONTAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PERIODONTAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PERIODONTAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY POSTOPERATIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY POSTOPERATIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY POSTOPERATIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY WHITENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY WHITENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY WHITENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CONVENIENCE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CONVENIENCE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DENTAL CLINICS & HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DENTAL CLINICS & HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DENTAL CLINICS & HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY E PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY E PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY E PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MARKETPLACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MARKETPLACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY MARKETPLACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SUPERMARKET/HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SUPERMARKET/HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SUPERMARKET/HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 182. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 185. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 207. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 209. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 210. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 212. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 215. G7 PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 216. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 218. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 219. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 220. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 221. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 224. NATO PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY GEL, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PRICE TIER, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA PHARMACEUTICAL MOUTHWASH MARKET SIZE, BY PHARMACY, 2018-2032 (USD MILLION)